1.Effects of traditional Chinese medicine Panax notoginoside(血塞通) and Tetramethylpyrazine(川芎嗪)on cytochrome P450 subtype enzymes
Jie SHI ; Anjin CHEN ; Fang ZHANG ; Benjian WANG
Chinese Journal of Integrated Traditional and Western Medicine in Intensive and Critical Care 2006;0(06):-
Objective To study the effects of traditional Chinese medicine Panax notoginoside(PNS,血塞通) and Tetramethylpyrazine(TMPz,川芎嗪) on different subtypes of cytochrome P450(CYP450),based on that,to forecast the inter-reaction between these two drugs and between each one of them and another drug,and also to estimate the safety assessment of them.Methods The metabolic changes of caffeine and dapsone which are the specific probe drugs for subtypes of CYP450,CYP1A2 and CYP3A4,were studied in vitro to estimate the inhibition or induction effects of PNS and TMPz.Results The concentrations of caffeine and dapsone,the probe drugs in liver cytochrome P450,in control group,PNS group and TMPz group were all declined with time prolongation,and there were no significant differences among the three groups.The half life time(t1/2) of caffeine in PNS group was obviously shorter than that in control group((19.24?2.37) minutes vs.(25.15?2.02) minutes, P0.05).It was suggested that TMPz have no effect on both CYP1A2 and CYP3A4.Conclusion Different drugs have different effects on different CYP450 subtype enzymes.When PNS is used in combination with other drugs which are related to the metabolism of CYP1A2 enzyme,its induction effect on CYP1A2 should be considered fully to avoid toxic effect or the potential adverse reactions.
2.Predictive value of anthropometric indicators for cardiovascular risk in metabolic syndrome
Qiyun LU ; Anxiang LI ; Benjian CHEN ; Qingshun LIANG ; Guanjie FAN ; Yiming TAO ; Ronghua ZHANG ; Fangfang DAI ; Xiaoling HU ; Yunwei LIU ; Yingxiao HE ; Ying ZHU ; Zhenjie LIU
Chinese Journal of Endocrinology and Metabolism 2023;39(1):26-33
Objective:To evaluate the predictive value of anthropometric indicators in predicting cardiovascular risk in the population with metabolic syndrome(MS).Methods:A cross-sectional study was used to analyze the correlation between anthropometric measures and cardiovascular risk in subjects with MS. Cardiometabolic risk was assessed with cardiometabolic risk index(CMRI). Receiver operating characteristic(ROC) curve analysis was used to assess the predictive power of anthropometric measures for cardiometabolic risk.Results:(1) The anthropometric measures [body mass index(BMI), waist-hip ratio(WHR), waist-to-height ratio(WtHR), body fat percentage(BFP), visceral fat index(VFI), conicity index(CI), a body shape index(ABSI), body roundness index(BRI), abdominal volume index(AVI)] in the MS group were significantly higher than those in the non-MS group( P<0.05). Moreover, there were significant differences in CMRI score and vascular risk between the two groups( P<0.05). (2) Logistic regression analysis showed that the cardiovascular risk was increased with the increases of BMI, VFI, WHR, WtHR, CI, BRI, and AVI after adjusting for confounding factors in the overall population, the non-MS population, and the MS population( P<0.05). (3) In the ROC analysis, the AUC values of BMI, VFI, and AVI were 0.767, 0.734, and 0.770 in the overall population; 0.844, 0.816, and 0.795 in the non-MS population; 0.701, 0.666, and 0.702 in the MS population, respectively. For the overall population and non-MS population, the optimal cut points of BMI to diagnose high cardiovascular risk were 26.04 kg/m 2 and 24.36 kg/m 2; the optimal cut points of VFI were 10.25 and 9.75; the optimal cut points of AVI were 17.3 cm 2 and 15.53 cm 2, respectively. In the MS population, the optimal cut point as a predictor of high cardiovascular risk in young and middle-aged men with MS was 27.63 kg/m 2, and the optimal cut point of AVI in women was 18.08 cm 2. Conclusion:BMI, VFI, and AVI can be used as predictors of cardiovascular risk in the general population. BMI can be used as a predicator of high cardiovascular risk in young and middle-age men with MS. AVI can be used as a predicator of high cardiovascular risk in women with MS.
3.The clinical experience of transnasal endoscopic approach for skull base osteoradionecrosis after radiotherapy for nasopharyngeal carcinoma.
Guiping LAN ; Bo HUANG ; Yongfeng SI ; Yangda QIN ; Zhuoxia DENG ; Yong YANG ; Ying QIN ; Benjian ZHANG
Chinese Journal of Otorhinolaryngology Head and Neck Surgery 2016;51(5):367-371
OBJECTIVETo investigate the method of surgical treatment via trans-nasal endoscopic approach in osteoradionecrosis of skull base after radiotherapy for nasopharyngeal carcinoma.
METHODSFifteen patients with osteoradionecrosis of skull base after radiotherapy for nasopharyngeal carcinoma who underwent operation via trans-nasal endoscopic approach from 2008 to 2013 were retrospectively reviewed. The typical clinical manifestations included headache (NRS 6-9: 11 cases), foul odor (10 cases), epistaxis (4 cases), hearing loss (5 cases, 7 ears), tinnitus (4 cases, 5 ears). All patients underwent operation via trans-nasal endoscopic approach. During the operation, the diseased region was fully exposed, the necrotic tissue was resected, the necrotic bone was removed by high-speed electric drill, and the drainage was made unobstructed. The perioperative treatment and follow-up were carried out.
RESULTSAfter operation, all patients were diagnosed pathologically as osteoradionecrosis and mucosal chroinic inflammation, 1 case combined with fungal sphenoid sinusitis. Headache (9 cases) and foul odor (9 cases) resolved after operation. The follow-up was lasted 18-82 months, 13 cases were survival, 1 case lost to follow-up, 1 case died of cerebral hemorrhage.
CONCLUSIONSurgical treatment via trans-nasal endoscopic approach is safe and effective in osteoradionecrosis of skull base after radiotherapy for nasopharyngeal carcinoma, and is helping to improve the survival rate and survival quality.
Carcinoma ; Endoscopy ; Humans ; Nasopharyngeal Neoplasms ; radiotherapy ; Osteoradionecrosis ; surgery ; Retrospective Studies ; Skull Base ; surgery ; Survival Rate
4. Diagnostic value of narrow-band imaging in detection of recurrent nasopharyngeal carcinoma
Jinyuan SI ; Jingjin WENG ; Benjian ZHANG ; Guiping LAN ; Yong YANG ; Bo HUANG ; Yongli WANG ; Ying QIN ; Bing LI ; Xing HAN ; Weiming XIONG ; Yongfeng SI
Chinese Journal of Otorhinolaryngology Head and Neck Surgery 2017;52(12):895-899
Objective:
To evaluate the diagnostic value and feasibility of narrow-band imaging in detection of recurrent nasopharyngeal carcinoma (NPC).
Methods:
One thousand three hundred and sixty-four NPC patients who had completed NPC treatment were enrolled. All patients were followed-up with imaging, serological examination of EB virus and nasopharyngeal endoscopy(WL and NBI mode), in which (1) both white light (WL) and NBI modes were done; (2) positive endoscopic patients were given nasopharyngeal biopsy; (3) using histologic finding as criterion standard, the sensitivity, specificity, accuracy and Yonden′s index of two modes were compared. Kappa index was used to evaluate the consistency between the two modes and pathological results respectively; (4) the positive rates of WL and NBI in patients with early recurrent (stage Ⅰ+ Ⅱ) were compared.
Results:
A total of 265 cases were suspected as having recurrent lesions by endoscopy in WL mode and 68 cases of them were pathologically diagnosed as having NPC; and 82 cases were suspected as having recurrent lesions by endoscopy in NBI mode and 74 cases of them were pathologically diagnosed as having NPC. The sensitivity, specificity, accuracy and Yonden′s index of WL mode were 91.89%, 0, 25.09% and -0.0811, respectively, with a kappa of -0.045; the sensitivity, specificity, accuracy and Yonden′s index of NBI mode were 100.00%, 95.94%, 97.05% and 0.9594, respectively.
Conclusion
NBI has higher sensitivity, specificity, early diagnosis rate and Yonden′s index than WL.
5.Efficacy and safety of three-dimensional visualization technology in assisting ablation therapy for hepatocellular carcinoma: A Meta-analysis
Kaifu LI ; Yongcheng TANG ; Hao TANG ; Xi ZHANG ; Benjian GAO ; De LUO ; Song SU ; Bo LI ; Xiaoli YANG
Journal of Clinical Hepatology 2024;40(7):1397-1403
ObjectiveTo systematically evaluate the efficacy and safety of three-dimensional visualization technology in assisting ablation therapy for hepatocellular carcinoma. MethodsThis study was conducted according to PRISMA guidelines, with a PROSPERO registration number of CRD42023488398. PubMed, Embase, Web of Science, the Cochrane Library, CNKI, Wanfang Data, VIP, and CBM were searched for Chinese and English articles on three-dimensional visualization technology in assisting ablation therapy for hepatocellular carcinoma published up to March 2023. After quality assessment and data extraction of the studies included, RevMan 5.4 software was used to perform the meta-analysis. ResultsA total of 11 studies were included, with 972 patients in total, among whom 447 underwent ablation assisted by three-dimensional visualization technology (3D group) and 525 underwent ablation assisted by traditional two-dimensional imaging technology (2D group). The meta-analysis showed that compared with the 2D group, the 3D group had significantly higher success rate of first-time ablation treatment (odds ratio [OR]=5.43, 95% confidence interval [CI]: 2.64 — 11.18, P<0.001), technical efficiency (OR=6.15, 95%CI: 3.23 — 11.70, P<0.001), and complete ablation rate (OR=2.50, 95%CI: 1.08 — 5.78, P=0.03), as well as significantly lower incidence rate of major complications (OR=0.45, 95%CI: 0.24 — 0.87, P=0.02), local recurrence rate (OR=0.35, 95%CI: 0.17 — 0.72, P=0.004), and local tumor progression rate (OR=0.29, 95%CI: 0.16 — 0.50, P<0.001), while there was no significant difference in the incidence rate of mild complications between the two groups (P>0.05). ConclusionThree-dimensional visualization technology is safe and feasible in assisting ablation therapy for hepatocellular carcinoma and can improve ablation rate and reduce the incidence rate of serious complications, local recurrence rate, and local tumor progression rate, thereby showing an important application value in clinical practice.